Schiffman, K. Et Al. 1996. Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. Bone Marrow Transplantation , vol.17, no.6 , 943-950.

Schiffman, K., Bensinger, W., Appelbaum, F., Rowley, S., Lilleby, K., Clift, R., ... Weaver, C.(1996). Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. Bone Marrow Transplantation , vol.17, no.6, 943-950.

Schiffman, K.S. Et Al. "Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease," Bone Marrow Transplantation , vol.17, no.6, 943-950, 1996

Schiffman, K.S. Et Al. "Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease." Bone Marrow Transplantation , vol.17, no.6, pp.943-950, 1996

Schiffman, K. Et Al. (1996) . "Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease." Bone Marrow Transplantation , vol.17, no.6, pp.943-950.

@article{article, author={K.S. Schiffman Et Al. }, title={Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease}, journal={Bone Marrow Transplantation}, year=1996, pages={943-950} }